• Other
  • Current

TranscripTx is developing locally delivered mRNA therapies for Primary Ciliary Dyskinesia — a rare genetic condition that can lead to chronic ear, sinus and pulmonary disease — and other life-threatening, genetic pulmonary diseases with limited or no treatment options.